Equities

Jeena Sikho Lifecare Ltd

Jeena Sikho Lifecare Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,388.70
  • Today's Change-30.15 / -2.12%
  • Shares traded17.10k
  • 1 Year change+138.06%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 10:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2021202120202019
ASSETS
Cash And Short Term Investments90147.07
Total Receivables, Net656157
Total Inventory93106127
Prepaid expenses0.158.569.39
Other current assets, total131932
Total current assets261209232
Property, plant & equipment, net225165126
Goodwill, net------
Intangibles, net1.791.390.83
Long term investments------
Note receivable - long term1.271.500
Other long term assets2.623.092.29
Total assets491380360
LIABILITIES
Accounts payable335777
Accrued expenses281717
Notes payable/short-term debt118118148
Current portion long-term debt/capital leases0.801.611.47
Other current liabilities, total634127
Total current liabilities243234271
Total long term debt1.534.956.56
Total debt120125156
Deferred income tax1.661.561.58
Minority interest------
Other liabilities, total4.782.250.69
Total liabilities251243280
SHAREHOLDERS EQUITY
Common stock1.011.001.00
Additional paid-in capital1.8900
Retained earnings (accumulated deficit)23813679
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity24113780
Total liabilities & shareholders' equity491380360
Total common shares outstanding252525
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.